Financhill
Back

KraneShares California Carbon Allowance Strat ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
38

KCCA
KraneShares California Carbon Allowance Strat ETF

Last Price:
$16.65
Seasonality Move:
-11.98%
Buy
78

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
38
KraneShares California Carbon Allowance Strat ETF (KCCA) is a Sell

Is KraneShares California Carbon Allowance Strat ETF a Buy, Sell or Hold?

  • The current KraneShares California Carbon Allowance Strat ETF [KCCA] share price is $16.66. The Score for KCCA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • KCCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KCCA Stock Price Chart

What is KraneShares California Carbon Allowance Strat ETF's stock price today?

  • The KraneShares California Carbon Allowance Strat ETF share price today is $16.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KCCA is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $39.6400
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.

KCCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 48.5 Sell
Chaikin Money Flow: 58676 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.32 - 16.84) Buy
Bollinger Bands (100): (16.03 - 17.53) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 66.31 Buy
Chaikin Money Flow: -583105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.9202 - 36.9202) Buy
Bollinger Bands (100): (20.9405 - 34.5405) Buy

KCCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.77 Sell
20-day SMA: 16.57 Buy
50-day SMA: 16.94 Sell
200-day SMA: 16.08 Buy
8-day EMA: 16.7 Sell
20-day EMA: 16.69 Sell
50-day EMA: 16.77 Sell
200-day EMA: 17.02 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Buy
20-day SMA: 35.4 Buy
50-day SMA: 33.69 Buy
200-day SMA: 22.3 Buy
8-day EMA: 30.99 Buy
20-day EMA: 18.54 Buy
50-day EMA: 8.93 Buy
200-day EMA: 2.46 Buy

KraneShares California Carbon Allowance Strat ETF Earnings Growth & KCCA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

KraneShares California Carbon Allowance Strat ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):